| 52-Week High | 219.57 |
|---|---|
| Last Price | 218.96 |
| Fibonacci 61.8% | 168.95 |
| Fibonacci 50% | 153.32 |
| Fibonacci 38.2% | 137.68 |
How much is a share of GW Pharmaceuticals worth?
One share of GWPH stock can currently be purchased for approximately $218.96. How much money does GW Pharmaceuticals make? GW Pharmaceuticals has a market capitalization of $6.86 billion and generates $311.33 million in revenue each year.
What does a hold rating mean for GW Pharmaceuticals (gwph)?
A hold rating indicates that analysts believe investors should maintain any existing positions they have in GWPH, but not buy additional shares or sell existing shares. View analyst ratings for GW Pharmaceuticals or view top-rated stocks. What stocks does MarketBeat like better than GW Pharmaceuticals?
What was the price of gwph on 27th May 2022?
Friday, 27th May 2022 GWPH stock ended at $218.96. During the day the stock fluctuated 0% from a day low at $218.96 to a day high of $218.96 . ... From 25 621, only a few dozen will trigger such a signal! Get Access to The Golden Star!
See more
Is GWPH a good stock to buy?
GW Pharma has 0.47% upside potential, based on the analysts' average price target. Can I see which stocks the top-ranking analysts are rating? Yes, go to the Analysts' Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
Is GW Pharmaceuticals publicly traded?
GW Leads the Pack Another top performing publicly traded cannabis company was GW Pharmaceuticals, which was acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ) for $225 per share earlier this year.
Has GW Pharmaceuticals been sold?
DUBLIN , May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.
How do I buy GW Pharmaceutical stock?
How to buy shares in GW PharmaceuticalsCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Who bought GW Pharmaceuticals?
Jazz PharmaceuticalsA big merger at the intersection of the marijuana and pharmaceutical industries is one step closer to completion. On Friday, shareholders of GW Pharmaceuticals (GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (JAZZ -1.84%), both companies announced in a joint press release.
When did GW Pharmaceuticals go public?
In 2001, GW Pharmaceuticals listed on the Alternative Investment Market, the junior market of the London Stock Exchange. In May 2013, the company became dual-listed on the NASDAQ and AIM.
How much did GW Pharmaceuticals sell for?
a $7.2 billion(Reuters) - Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal which will bolster its neuroscience business with the addition of a cannabis-based epilepsy treatment.
What happened to GW Pharmaceuticals Plc?
Jazz Pharmaceuticals (NASDAQ:JAZZ) has officially closed its $7.2B acquisition of GW Pharmaceuticals plc (NASDAQ:GWPH). GW shareholders gave the thumbs up to the deal last month. With the acquisition, Jazz gains access to GW's cannabinoid portfolio, including Epidiolex, which raked in $510.5M in sales in 2020.
How much did jazz Buy GW for?
$7.2 billionJazz agreed to pony up $7.2 billion for cannabinoid hotshot GW Pharmaceuticals, whose epilepsy med Epidiolex could be on its way to blockbuster sales. The deal will move Jazz into the epilepsy market, expanding its current offerings beyond sleep disorders and cancer.
Who did GW Pharmaceuticals merge with?
Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ 0.00%) and GW Pharmaceuticals are now under the same corporate roof. The two companies announced Wednesday that Jazz's acquisition of GW has been completed. This brings the $7.6 billion cash-and-stock deal, first announced in early February, to a close.
What is GW company?
GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas.
What does jazz Pharma do?
Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully.
What does jazz pharmaceuticals make?
Pharmaceutical drugsJazz PharmaceuticalsTypePublic companyProductsPharmaceutical drugsBrandsXyrem Erwinaze Defitelio FazaClo FazaClo HD Luvox CR Prialt VyxeosRevenueUS$1.618 billion (2017)Operating incomeUS$528.8 million (2017)13 more rows
Where is GW Pharmaceuticals located?
Overview Suggest EditTypePublicFounded1998HQCambridge, GBWebsitegwpharm.comEmployee Ratings3.81 more row
What company owns Epidiolex?
GW Pharmaceuticals' (GWPH) cannabidiol (CBD) drug Epidiolex has been granted Food and Drug Administration approval for a new indication. Additionally, its previous approval has been expanded to cover a wider age range of patients.
What is the cost of Epidiolex?
Epidiolex rollout: $32,500 list price spurs critics as first cannabis drug hits shelves. It's official—the first FDA approved CBD product is on the market. GW Pharmaceuticals announced this morning that its cannabinoid Epidiolex, approved in the treatment of two rare forms of epilepsy, is now available by prescription.
How many employees does GW Pharmaceuticals have?
Number of employees at GW Pharmaceuticals as of 2020, by function. As of December 2020, GW Pharmaceuticals had around 355 employees in the area of research and development, while there were 218 employees in management and administration.
Who makes Epidyolex?
GW Pharmaceuticals (GW), a subsidiary of Jazz Pharmaceuticals plc , has established a world-leading position in cannabinoid science and medicine. Founded over two decades ago in response to significant unmet patient need, patients remain our key focus and improving their quality of life, our motivation.
Where is Epidiolex manufactured?
Manufactured by U.K.-based GW Pharmaceuticals, the cannabis drug is derived from a plant that has been bred to have a high cannabidiol, or CBD, content.
What company owns Epidiolex?
GW Pharmaceuticals' (GWPH) cannabidiol (CBD) drug Epidiolex has been granted Food and Drug Administration approval for a new indication. Additionally, its previous approval has been expanded to cover a wider age range of patients.
What is GW company?
GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas.
How do you purchase stock?
To buy stocks, you'll typically need the assistance of a stockbroker, since you cannot simply call up a stock exchange and ask to buy stocks directly. When you use a stockbroker, whether a human being or an online platform, you can choose the investment that you wish to buy or sell and how the trade should be handled.
How many employees does GW Pharmaceuticals have?
Number of employees at GW Pharmaceuticals as of 2020, by function. As of December 2020, GW Pharmaceuticals had around 355 employees in the area of research and development, while there were 218 employees in management and administration.
How were GW Pharmaceuticals' earnings last quarter?
GW Pharmaceuticals plc (NASDAQ:GWPH) released its quarterly earnings results on Tuesday, November, 3rd. The biopharmaceutical company reported ($0....
Who are GW Pharmaceuticals' key executives?
GW Pharmaceuticals' management team includes the following people: Mr. Justin D. Gover , CEO & Exec. Director (Age 50, Pay $1.19M) ( LinkedIn Pr...
What is Justin Gover's approval rating as GW Pharmaceuticals' CEO?
14 employees have rated GW Pharmaceuticals CEO Justin Gover on Glassdoor.com . Justin Gover has an approval rating of 80% among GW Pharmaceuticals...
Who are some of GW Pharmaceuticals' key competitors?
Some companies that are related to GW Pharmaceuticals include Royalty Pharma (RPRX) , MERCK Kommanditgesellschaft auf Aktien (MKGAF) , Takeda Ph...
What other stocks do shareholders of GW Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other GW Pharmaceuticals investors own include (CGC) , NVIDIA...
What is GW Pharmaceuticals' stock symbol?
GW Pharmaceuticals trades on the NASDAQ under the ticker symbol "GWPH."
What is GW Pharmaceuticals' stock price today?
One share of GWPH stock can currently be purchased for approximately $218.96.
How much money does GW Pharmaceuticals make?
GW Pharmaceuticals (NASDAQ:GWPH) has a market capitalization of $6.86 billion and generates $311.33 million in revenue each year. The biopharmaceut...
How many employees does GW Pharmaceuticals have?
GW Pharmaceuticals employs 1,161 workers across the globe.